1-5 of 5
Nicholas S. Duesbery
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma

Free
Nicholas J. Andersen, Brian J. Nickoloff, Karl J. Dykema, Elissa A. Boguslawski, Roman I. Krivochenitser, Roe E. Froman, Michelle J. Dawes, Laurence H. Baker, Dafydd G. Thomas, Debra A. Kamstock, Barbara E. Kitchell, Kyle A. Furge, Nicholas S. Duesbery
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (9): 1701–1714.
https://doi.org/10.1158/1535-7163.MCT-12-0893
Published: 05 September 2013
View article titled, Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma
Open the PDF for Pharmacologic Inhibition of MEK Signaling Prevents Growth of Canine Hemangiosarcoma in another window
Includes: Supplementary data
Journal Articles

Inhibition of Tumor Angiogenesis by the Matrix Metalloproteinase–Activated Anthrax Lethal Toxin in an Orthotopic Model of Anaplastic Thyroid Carcinoma

Free
Randall W. Alfano, Stephen H. Leppla, Shihui Liu, Thomas H. Bugge, Janelle M. Ortiz, Terry C. Lairmore, Nicholas S. Duesbery, Ian C. Mitchell, Fiemu Nwariaku, Arthur E. Frankel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (1): 190–201.
https://doi.org/10.1158/1535-7163.MCT-09-0694
Published: 12 January 2010
View article titled, Inhibition of Tumor Angiogenesis by the Matrix Metalloproteinase–Activated Anthrax Lethal Toxin in an Orthotopic Model of Anaplastic Thyroid Carcinoma
Open the PDF for Inhibition of Tumor Angiogenesis by the Matrix Metalloproteinase–Activated Anthrax Lethal Toxin in an Orthotopic Model of Anaplastic Thyroid Carcinoma in another window
Includes: Supplementary data
Journal Articles

Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells

Free
Randall W. Alfano, Stephen H. Leppla, Shihui Liu, Thomas H. Bugge, Meenhard Herlyn, Keiran S. Smalley, Jennifer L. Bromberg-White, Nicholas S. Duesbery, Arthur E. Frankel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (5): 1218–1226.
https://doi.org/10.1158/1535-7163.MCT-08-0024
Published: 15 May 2008
View article titled, Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells
Open the PDF for Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells in another window
Includes: Supplementary data
Journal Articles

Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma

Free
Yan Ding, Elissa A. Boguslawski, Bree D. Berghuis, John J. Young, Zhongfa Zhang, Kim Hardy, Kyle Furge, Eric Kort, Arthur E. Frankel, Rick V. Hay, James H. Resau, Nicholas S. Duesbery
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (3): 648–658.
https://doi.org/10.1158/1535-7163.MCT-07-2229
Published: 17 March 2008
View article titled, Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma
Open the PDF for Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma in another window
Includes: Supplementary data
Journal Articles

BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin

Free
Ralph J. Abi-Habib, Jeffrey O. Urieto, Shihui Liu, Stephen H. Leppla, Nicholas S. Duesbery, Arthur E. Frankel
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (9): 1303–1310.
https://doi.org/10.1158/1535-7163.MCT-05-0145
Published: 16 September 2005
View article titled, BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
Open the PDF for BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin in another window